Shares of Hoya Corp. (OTCMKTS:HOCPY - Get Free Report) passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $124.02 and traded as high as $131.28. Hoya shares last traded at $129.77, with a volume of 8,581 shares.
Analyst Upgrades and Downgrades
Several equities research analysts recently weighed in on the stock. The Goldman Sachs Group raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a report on Wednesday, July 23rd. Erste Group Bank raised shares of Hoya from a "hold" rating to a "strong-buy" rating in a report on Friday, May 23rd. Finally, Nomura Securities raised shares of Hoya to a "strong-buy" rating in a report on Monday, August 18th. Three analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, the stock has a consensus rating of "Strong Buy".
View Our Latest Report on Hoya
Hoya Stock Up 0.5%
The company has a debt-to-equity ratio of 0.03, a quick ratio of 4.46 and a current ratio of 5.19. The company has a market capitalization of $44.97 billion, a price-to-earnings ratio of 32.76, a P/E/G ratio of 2.75 and a beta of 0.91. The stock's fifty day simple moving average is $124.89 and its two-hundred day simple moving average is $119.89.
Hoya (OTCMKTS:HOCPY - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The technology company reported $1.05 earnings per share for the quarter, beating analysts' consensus estimates of $1.04 by $0.01. Hoya had a net margin of 23.57% and a return on equity of 21.01%. The company had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.47 billion. On average, sell-side analysts anticipate that Hoya Corp. will post 3.66 EPS for the current year.
About Hoya
(
Get Free Report)
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
See Also
Before you consider Hoya, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hoya wasn't on the list.
While Hoya currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.